Skip to main content
. 2017 Sep 16;6(4):313–324. doi: 10.1159/000480441

Fig. 3.

Fig. 3

Kaplan-Meier curves describing the differences in overall survival of patients classified according to prior treatment status following stratification by the type of therapy received after permanent sorafenib cessation: best supportive care (BSC) (a) or further active anticancer therapies (b).